BRAVA CRT-D,BRAVA QUARD CRT-D,CONCERTO II CRT-D, CONSULTA CRT-D,MAXIMOII CRT-D, PROTECTA CRT-D, PROTECTA XT CRT-D, VIVA
FDA premarket approval P010031/S514 · decided 2015-10-22
Approval details
- PMA number
- P010031
- Supplement
- S514
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- BRAVA CRT-D,BRAVA QUARD CRT-D,CONCERTO II CRT-D, CONSULTA CRT-D,MAXIMOII CRT-D, PROTECTA CRT-D, PROTECTA XT CRT-D, VIVA
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2015-09-30
- Decision date
- 2015-10-22
- Days to decision
- 22 days
- Decision code
- OK30
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- UPDATE THE MANUFACTURING EXECUTION SYSTEM (MES) TO FACTORY WORKS 9.1, IMPM MES WEB SERVICES 3.0.0, AND OTHER ASSOCIATED CHANGES.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.